GDF15 and metabolic dysfunction-associated steatohepatitis: They reported that WAT is the primary source of GDF15 at the onset of obesity and T2D (due to macrophage accumulation), while the liver becomes more involved during progression to MASH, with GDF15 expression rising in hepatocytes as the disease advances (L'Homme et al. 2024).